TLC BioSciences Corp. (TPEX:7924)

TLC BioSciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep 23, 2026	Dec 31, 2025	Dec 31, 2024
Debt / Equity Ratio	0.49	-0.26	-0.42
Net Debt / Equity Ratio	-0.45	-0.07	0.02
Net Debt / EBITDA Ratio	0.46	-0.46	0.08
Net Debt / FCF Ratio	0.79	-0.56	0.07
Asset Turnover	-	0.05	-
Inventory Turnover	-	0.30	-
Quick Ratio	1.67	0.14	0.27
Current Ratio	2.17	0.19	0.33
Return on Assets (ROA)	-	-21.30%	-
Return on Capital Employed (ROCE)	-98.10%	17.80%	29.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep 23, 2026	Dec 31, 2025	Dec 31, 2024
Buyback Yield / Dilution	-	-8.65%	-

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 28, 2026

Data Sources Report a data error